ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

塩酸シクロベンザプリン

Cyclobenzaprine Hydrochloride

HCID 22576
反応を作成
印刷
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
6202-23-9
標準SMILES
CN(C)CCC=C1c2ccccc2C=Cc2ccccc21.Cl
InChIKey
VXEAYBOGHINOKW-UHFFFAOYSA-N
分子式
C20H22ClN
平均分子量
311.8 g/mol
単同位体質量
311.14407738

概要

Cyclobenzaprine hydrochloride is the hydrochloride salt of cyclobenzaprine. A centrally acting skeletal muscle relaxant, it is used in the symptomatic treatment of painful muscle spasm. It has a role as an antidepressant and a muscle relaxant. It contains a cyclobenzaprine. It derives from a hydride of a dibenzo[a,d][7]annulene.

名称と識別子

優先名称
Cyclobenzaprine Hydrochloride
IUPAC
N,N-dimethyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)propan-1-amine;hydrochloride
現地名
塩酸シクロベンザプリン
英語名
Cyclobenzaprine hydrochloride
分子式
C20H22ClN
分子量
311.85

名称と別名

Cyclobenzaprine hydrochloride6202-23-9Cyclobenzaprine HCLFlexerilFlexibanAmrixCycloflexClobenNovo-CycloprineTabradolTNX-102DTXSID2045105
名称をさらに表示
3-(5H-ジベンゾ[a,d]シクロヘプテン-5-イリデン)-N,N-ジメチル-1-プロパンアミン·塩酸塩フレキシバンフレキセリルリッセリルプロヘプタトリエン塩酸塩シクロベンザプリン塩酸塩5-(3-ジメチルアミノプロピリデン)ジベンゾ[a,e]シクロヘプタトリエン塩酸塩塩酸シクロベンザプリンシクロベンザプリン 塩酸塩シクロベンザプリン 塩酸塩 溶液3-(5H-ジベンゾ[a,d]シクロヘプテン-5-イリデン)-N,N-ジメチル-1-プロパンアミン・塩酸塩シクロベンザプリン・塩酸塩FlexibaLisserilCyclobezaprine HClMK130 hydrochlorideNortriptyline EP Impurity EAmitriptyline EP Impurity B
CYCLOBENZAPRINE HCI0VE05JYS2PNSC-78206NSC-169900NSC-17337910,11delta-Amitriptyline hydrochlorideCHEBI:3997DTXCID0025105

物性

構造計算による物性

極性表面積
3.2 Ų
水素結合供与体数
1
水素結合受容体数
1
回転可能結合数
3
重原子数
22
形式電荷
0
複雑度
365

実験および物理化学的性質

Human Drugs · 3 件

Breast Feeding; Lactation; Milk, Human; Muscle Relaxants, Central

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

物理化学的性質

融点
216 · 216-2180C
闪点
9 ℃ · 9℃
貯蔵温度
Inert atmosphere,Room Temperature
水溶解度
Completely soluble in water
溶解性
15.59 mg/mL · ≥15.59 mg/mL in DMSO; ≥5.32 mg/mL in EtOH; ≥54.3 mg/mL in H2O
外見
Solid
色
White to Almost white
Merck
14 · 14,2713
主な用途
医薬品(低分子化合物)
InChI
1S/C20H21N.ClH/c1-21(2)15-7-12-20-18-10-5-3-8-16(18)13-14-17-9-4-6-11-19(17)20;/h3-6,8-14H,7,15H2,1-2H3;1H
InChIKey
VXEAYBOGHINOKW-UHFFFAOYSA-N
SMILES
Cl.CN(C)CC\C=C1\c2ccccc2C=Cc3ccccc13
CAS データベース
6202 · 6202-23-9(CAS DataBase Reference)

化学的性質

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 5 件

This chemical does not meet GHS hazard criteria for 1.8% (1 of 55) of reports.

Danger

H301 (89.1%): Toxic if swallowed [Danger Acute toxicity, oral]

P261, P264, P270, P271, P272, P280, P301+P316, P302+P352, P304+P340, P317, P321, P330, P333+P317, P362+P364, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 55 reports by companies from 9 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

危険有害性情報

Regulatory Information1-Propanamine, 3-(5H-dibenzoa,dcyclohepten-5-ylidene)-N,N-dimethyl-, hydrochloride: Does not have an individual approval but may be used under an appropriate group standard
Other Safety InformationIMAP assessments - 1-Propanamine, 3-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethyl-, hydrochloride: Environment tier I assessment
Hazard Classes and CategoriesAcute Tox. 3 (89.1%)

毒性情報

Drug Induced Liver Injury · 6 件

Drug Induced Liver Injury Rank (DILIrank 2.0)

Cyclobenzaprine hydrochloride

vLess-DILI-concern

5

Adverse reactions

DOI:10.1016/j.drudis.2016.02.015

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation

安全データ

wgk
3

化学と産業

薬理情報

FDA Pharmacological Classification · 6 件

CYCLOBENZAPRINE HCL

Centrally-mediated Muscle Relaxation [PE]; Muscle Relaxant [EPC]

CYCLOBENZAPRINE HCL ER

Centrally-mediated Muscle Relaxation [PE]; Muscle Relaxant [EPC]

CYCLOBENZAPRINE HYDROCHLORIDE

Centrally-mediated Muscle Relaxation [PE]; Muscle Relaxant [EPC]

MeSH Pharmacological Classification · 3 件

Substances that contain a fused three-ring moiety and are used in the treatment of depression. These drugs block the uptake of norepinephrine and serotonin into axon terminals and may block some subtypes of serotonin, adrenergic, and histamine receptors. However, the mechanism of their antidepressant effects is not clear because the therapeutic effects usually take weeks to develop and may reflect compensatory changes in the central nervous system.

A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358)

A traditional grouping of drugs said to have a soothing or calming effect on mood, thought, or behavior. Included here are the ANTI-ANXIETY AGENTS (minor tranquilizers), ANTIMANIC AGENTS, and the ANTIPSYCHOTIC AGENTS (major tranquilizers). These drugs act by different mechanisms and are used for different therapeutic purposes.

応用分野 · 3 件

説明Cyclobenzaprine is a skeletal muscle relaxant that also has sedative properties. It has been shown to antagonize muscarinic receptors (Kis = 25, 60, and 6 nM for M1, M2, and M3, respectively), serotonin 5-HT2 receptors (Kis = 56 and 330 nM for 5-HT2C and 5-HT2B, respectively), and histamine H1 receptor (IC50 = 20 nM).

Cyclobenzaprine hydrochloride cam be used as muscle relaxant (skeletal).

関連反応

3 件
反応記録を作成
HRID 2061222 の反応式
HRID 2061222反応物として
HRID 2236003 の反応式
HRID 2236003反応物として
HRID 2374821 の反応式
HRID 2374821反応物として

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート

データベース識別子

CAS
6202-23-9
PubChem CID
22576
DTXSID
DTXSID2045105
ChEMBL
CHEMBL1200636
ChEBI
CHEBI:3997
UNII
0VE05JYS2P
EC Number
228-264-4

化学的特性Crystalline Solid

rtecs
HP0875000
ridadr
UN 2811 6.1/PG 3
毒性
LD50 in mice (mg/kg): 35 i.v., 250 orally (Metysova)
hs_code
29214990
risk_code
20/21/22-39/23/24/25-23/24/25-11
hazard_code
Xn,T,F
safety_code
36-45-36/37-16-7
hazard_class
6.1(b)
packing_group
III
Hazard Classifications
Acute Tox. 3 OralAcute Tox. 4 DermalAcute Tox. 4 Inhalation
ストレージクラス
6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
使用

一般的な説明Cyclobenzaprine is a tricyclic agent, which has anti-depressant and anti-cholinergic properties. It lowers the tonic somatic motor activity of motor neuron systems. Cyclobenzaprine prevents the uptake ofnoradrenaline. It is used to treat neck,back and myofascial pain. Cyclobenzaprine functions as a nerve impulse inhibitor.

上流・下流製品情報

上流原料

塩酸N,N-ジメチル-3-クロロ-1-プロパンアミン

補足説明

定義ChEBI: The hydrochloride salt of cyclobenzaprine. A centrally acting skeletal muscle relaxant, it is used in the symptomatic treatment of painful muscle spasm.